当前位置: X-MOL 学术Nat. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels
Nature Medicine ( IF 82.9 ) Pub Date : 2017-08-21 00:00:00 , DOI: 10.1038/nm.4390
Sumeet A Khetarpal , Xuemei Zeng , John S Millar , Cecilia Vitali , Amritha Varshini Hanasoge Somasundara , Paolo Zanoni , James A Landro , Nicole Barucci , William J Zavadoski , Zhiyuan Sun , Hans de Haard , Ildikó V Toth , Gina M Peloso , Pradeep Natarajan , Marina Cuchel , Sissel Lund-Katz , Michael C Phillips , Alan R Tall , Sekar Kathiresan , Paul DaSilva-Jardine , Nathan A Yates , Daniel J Rader

On the basis of new mechanistic studies of a mutant form of the apolipoprotein apoC-III that protects against coronary heart disease, Khetarpal et al. have developed therapeutic apoC-III-targeting monoclonal antibodies that lower circulating apoC-III protein and triglyceride levels in mice.

中文翻译:

人类APOC3错义变体和单克隆抗体可加速apoC-III清除并降低富含甘油三酸酯的脂蛋白水平

根据新的机制研究,载脂蛋白apoC-III突变形式可预防冠心病,Khetarpal等人。已经开发了靶向治疗apoC-III的单克隆抗体,该抗体可降低小鼠体内循环apoC-III蛋白质和甘油三酸酯的水平。
更新日期:2017-09-09
down
wechat
bug